Last $6.79 USD
Change Today -0.31 / -4.37%
Volume 42.9K
ARGS On Other Exchanges
Symbol
Exchange
NASDAQ GM
Berlin
As of 8:10 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark T. Weedon MBA

Former President, Chief Executive Officer and Director, Argos Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 20 board members in 1 different organizations across 3 different industries.

See Board Relationships
----

Background*

Mr. Mark T. Weedon, MBA serves as a Principal of BWA Consulting, a business group. Mr. Weedon served as President and Chief Executive Officer of Argos Therapeutics, Inc. (Formerly MERIX Bioscience, Inc.). Mr. Weedon joined Argos Therapeutics, Inc., in January 2001. Mr. Weedon has over 25 years of experience in the pharmaceutical industry; most recently he was with Scriptgen (now Anadys) Pharmaceuticals as President and Chief Executive Officer. In the prior decade at ...

Read Full Background

Corporate Headquarters*

4233 Technology Drive
Durham, North Carolina 27704

United States

Phone: 919-287-6300
Fax: --

Board Members Memberships*

Former President, Chief Executive Officer and Director
Former Director
Director

Education*

BA
University of Toronto
MBA
The University Of Western Ontario
MBA
University of Western Ontario, Ivey School of Business

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ARGS:US $6.79 USD -0.31

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Douglas J. Swirsky CPA, CFAChief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, Treasurer, Corporate Secretary and Director
GenVec, Inc.
$316.3K
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Daniel J. O’Connor Esq.Chief Executive Officer, President and Director
Advaxis, Inc.
$312.5K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
William D. Clark Chief Executive Officer, President and Director
Genocea Biosciences, Inc.
$334.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARGOS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.